The ubiquitin-conjugating enzyme UBE2QL1 coordinates lysophagy in response to endolysosomal damage.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
04 10 2019
Historique:
received: 27 02 2019
revised: 02 08 2019
accepted: 07 08 2019
pubmed: 23 8 2019
medline: 12 5 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

The autophagic clearance of damaged lysosomes by lysophagy involves extensive modification of the organelle with ubiquitin, but the underlying ubiquitination machinery is still poorly characterized. Here, we use an siRNA screening approach and identify human UBE2QL1 as a major regulator of lysosomal ubiquitination, lysophagy, and cell survival after lysosomal damage. UBE2QL1 translocates to permeabilized lysosomes where it associates with damage sensors, ubiquitination targets, and lysophagy effectors. UBE2QL1 knockdown reduces ubiquitination and accumulation of the critical autophagy receptor p62 and abrogates recruitment of the AAA-ATPase VCP/p97, which is essential for efficient lysophagy. Crucially, it affects association of LC3B with damaged lysosomes indicating that autophagosome formation was impaired. Already in unchallenged cells, depletion of UBE2QL1 leads to increased lysosomal damage, mTOR dissociation from lysosomes, and TFEB activation pointing to a role in lysosomal homeostasis. In line with this, mutation of the homologue ubc-25 in Caenorhabditis elegans exacerbates lysosome permeability in worms lacking the lysosome stabilizing protein SCAV-3/LIMP2. Thus, UBE2QL1 coordinates critical steps in the acute endolysosomal damage response and is essential for maintenance of lysosomal integrity.

Identifiants

pubmed: 31432621
doi: 10.15252/embr.201948014
pmc: PMC6776906
doi:

Substances chimiques

Caenorhabditis elegans Proteins 0
Galectins 0
MAP1LC3A protein, human 0
Microtubule-Associated Proteins 0
Nuclear Proteins 0
RNA, Small Interfering 0
SQSTM1 protein, human 0
Sequestosome-1 Protein 0
UBC-25 protein, C elegans 0
Ubiquitin 0
Ubiquitins 0
UBE2QL1 protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23
Adenosine Triphosphatases EC 3.6.1.-
p97 ATPase EC 3.6.1.-
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e48014

Subventions

Organisme : EC|FP7|FP7 Ideas: European Research Council FP7 Ideas
ID : AdG 340751
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : Me1626/5-1
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : Me1626/4-2
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC2145
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1177
Pays : International
Organisme : Boehringer Ingelheim Foundation
Pays : International
Organisme : Danish National Research Foundation
ID : DNRF125
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Cell Rep. 2016 Oct 18;17(4):931-940
pubmed: 27760323
Hum Mutat. 2013 Dec;34(12):1650-61
pubmed: 24000165
Biochem Biophys Res Commun. 2003 Jun 6;305(3):691-9
pubmed: 12763049
Biochem J. 2016 Oct 15;473(20):3401-3419
pubmed: 27729585
Nat Cell Biol. 2010 Sep;12(9):823-30
pubmed: 20811354
Arch Neurol. 2011 Nov;68(11):1440-6
pubmed: 22084127
Cell Res. 2016 Apr;26(4):423-40
pubmed: 27002219
Nat Rev Mol Cell Biol. 2018 Jan 23;19(2):93-108
pubmed: 29358684
EMBO J. 2018 Nov 2;37(21):
pubmed: 30314966
Autophagy. 2019 Jun;15(6):1082-1099
pubmed: 30654731
Oncogene. 2008 Oct 27;27(50):6434-51
pubmed: 18955971
Cytotechnology. 2010 Jul;62(3):189-94
pubmed: 20424915
Cell Death Differ. 2013 Jan;20(1):21-30
pubmed: 22722335
Cell Res. 2016 Apr;26(4):484-98
pubmed: 27002218
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
EMBO J. 2013 Aug 28;32(17):2336-47
pubmed: 23921551
Mol Cell Proteomics. 2018 Jul;17(7):1295-1307
pubmed: 29599191
Science. 2018 Apr 6;360(6384):
pubmed: 29622626
J Cell Sci. 2002 Jul 15;115(Pt 14):3007-14
pubmed: 12082160
Cell. 2017 Apr 6;169(2):350-360.e12
pubmed: 28388416
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
EMBO J. 2017 Jan 17;36(2):135-150
pubmed: 27753622
Nature. 2012 Jan 15;482(7385):414-8
pubmed: 22246324
J Cell Sci. 2014 Sep 15;127(Pt 18):3877-83
pubmed: 25146396
Dev Cell. 2016 Oct 10;39(1):13-27
pubmed: 27693506
Nature. 2010 Jan 28;463(7280):549-53
pubmed: 20111001
Nat Commun. 2013;4:2111
pubmed: 23817530
Nat Rev Mol Cell Biol. 2009 Nov;10(11):755-64
pubmed: 19851334
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8574-8579
pubmed: 28743755
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Mol Cells. 2018 Mar 31;41(3):168-178
pubmed: 29562734
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Mol Syst Biol. 2009;5:237
pubmed: 19156129
J Cell Biol. 2016 Oct 24;215(2):167-185
pubmed: 27810910
Mol Cell. 2018 Apr 5;70(1):120-135.e8
pubmed: 29625033
EMBO Rep. 2019 Oct 4;20(10):e48014
pubmed: 31432621
Mol Cell. 2018 Jan 18;69(2):182-194
pubmed: 29153394
Curr Biol. 2017 Dec 18;27(24):R1330-R1341
pubmed: 29257971
EMBO J. 2018 Mar 1;37(5):
pubmed: 29343546
EMBO J. 2017 Jan 17;36(2):129-131
pubmed: 27895087
Annu Rev Biophys. 2014;43:357-79
pubmed: 24773014
Nat Rev Mol Cell Biol. 2013 May;14(5):283-96
pubmed: 23609508
Autophagy. 2015;11(8):1408-24
pubmed: 26114578
J Cell Biol. 2013 Oct 14;203(1):115-28
pubmed: 24100292
J Cell Sci. 2017 Sep 15;130(18):3124-3140
pubmed: 28754686
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Cancer Cell. 2013 Sep 9;24(3):379-93
pubmed: 24029234
Mol Cell. 2017 Nov 16;68(4):786-796.e6
pubmed: 29149599
Cell Rep. 2013 Apr 25;3(4):1306-20
pubmed: 23602568
Curr Opin Cell Biol. 2011 Aug;23(4):476-82
pubmed: 21705204
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Cell Commun Signal. 2015 Feb 15;13:10
pubmed: 25885255

Auteurs

Lisa Koerver (L)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Chrisovalantis Papadopoulos (C)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Bin Liu (B)

Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.

Bojana Kravic (B)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Giulia Rota (G)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Lukas Brecht (L)

Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, München, Germany.

Tineke Veenendaal (T)

Section Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Mira Polajnar (M)

Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, München, Germany.

Anika Bluemke (A)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Michael Ehrmann (M)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Judith Klumperman (J)

Section Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Marja Jäättelä (M)

Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.

Christian Behrends (C)

Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität München, München, Germany.

Hemmo Meyer (H)

Faculty of Biology, Centre for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH